A large study of electronic health records has uncovered four common patterns of medical conditions that tend to unfold in ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.

The study, which analyzed data on 1.2 million people with dementia, found improvements in five out of eight global regions ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow Alzheimer’s disease. A new study suggests that these common ...

The Alzheimer’s Assoc. is preparing guidelines on blood-based biomarker tests (anticipated in 2025), cognitive assessment tools (also anticipated in 2025), and clinical implementation of staging ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test detects signs of amyloid plaque build-up in the brain.

With Alzheimer’s disease now affecting more than 7M Americans, the public’s call for early diagnosis & treatment has never been louder.

The first new guidelines for diagnosing Alzheimer's disease in nearly 30 years establish earlier stages of the mind-robbing disease, paving the way for spotting and possibly treating these ...